2023 Form 5500 filing — The Leukemia & Lymphoma Society, Inc. 403(B) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241002123048NAL0004006915001) for The Leukemia & Lymphoma Society, Inc. 403(B) Plan, reported by The Leukemia & Lymphoma Society, Inc. 403(B) Plan under EIN 13-5644916 and plan number 002. It reports 1,596 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241002123048NAL0004006915001
Filing year
2023
Form type
2
Plan sponsor
The Leukemia & Lymphoma Society, Inc. 403(B) Plan
EIN
13-5644916
Plan number
002
Location
Rye Brook, NY
Participants
1,596
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$117,472,817
Total liabilities (EOY)
$0
Net assets (EOY)
$117,472,817
Employer contributions
$3,123,883
Participant contributions
$6,800,006
Total income / additions
$27,874,520
Benefits paid
$7,332,861
Administrative expenses
$238,819
Total expenses
$7,610,119
Net increase / (decrease)
$20,264,401
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Empower Annuity Insurance Company ORECORDKEEPER$139,604$0
R.V. Kuhns & Associates, Inc.NONE$73,189not reported in the loaded dataset
Withum Smith+BrownNONE$26,000not reported in the loaded dataset

Related Form 5500 pages